Takahiro Komori, Takeo Kosaka, Tomoki Tanaka, Keitaro Watanabe, Yota Yasumizu, Shuji Mikami, Mototsugu Oya. Locally recurrent prostate cancer with RB1/TP53 alterations successfully treated by salvage focal brachytherapy: a case report. American journal of clinical and experimental urology. 2023. 11. 4. 339-343
Takahiro Komori, Takeo Kosaka, Keitaro Watanabe, Tomoki Tanaka, Yota Yasumizu, Hiroshi Hongo, Shuji Mikami, Toshio Ohashi, Mototsugu Oya. Salvage focal brachytherapy in castration-resistant prostate cancer with neuroendocrine differentiation after radiation therapy. IJU Case Reports. 2022. 5. 4. 233-236
Kobayashi H, Eriguchi T, Tanaka T, Ogata T, Ishida M, Nakajima Y, Kumabe A, Kosugi M. Distribution analysis of hydrogel spacer and evaluation of rectal dose reduction in Japanese prostate cancer patients undergoing stereotactic body radiation therapy. International Journal of Clinical Oncology. 2021. 26. 4. 736-743
Shuichi Nishimura, Toshio Ohashi, Tetsuo Momma, Masanori Sakayori, Takahisa Eriguchi, Tomoki Tanaka, Shoji Yamashita, Takeo Kosaka, Mototsugu Oya, Naoyuki Shigematsu. Prostate-specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low-dose-rate brachytherapy or external beam radiotherapy for localized prostate cancer. Cancer Medicine. 2018. 7. 5. 1794-1801
Keisuke Shigeta, Eiji Kikuchi, Masashi Mastushima, Toshiyuki Ando, Takeo Kosaka, Ryuichi Mizuno, Akira MIyajima, Tomoaki Tanaka, Toshio Ohashi, Mototsugu Oya. ASSOCIATION OF RADIATION DOSES WITH DEVELOPMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH PERMANENT PROSTATE BRACHYTHERAPY. JOURNAL OF UROLOGY. 2017. 197. 4. E317-E317